Stocktoria
GT Biopharma, Inc. GTBP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2013-10-22
GT Biopharma, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Breen Michael Martin | Executive Chairman/Interim CEO | 2023-08-11 | Grant | 200,000 | $0.29 |
| Ohri Manu | CFO & Secretary | 2023-08-11 | Grant | 200,000 | $0.29 |
| Ohri Manu | CFO & Secretary | 2023-08-11 | J | 200,000 | $0.29 |
| Ohri Manu | CFO & Secretary | 2023-08-11 | J | 200,000 | $0.29 |
| Breen Michael Martin | Executive Chairman/Interim CEO | 2023-04-11 | Buy | 50,000 | $0.50 |
Source: SEC EDGAR filings · CIK 0000109657 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.